$HIMS 20260529 20.5 PUT$ I am bullish in Hims. Hims & Hers Health (HIMS) is heavily expanding its GLP-1 weight-loss offerings and platform, recently bringing access to generic semaglutide to Canada. To fund international growth and AI investments, the company priced an upsized $350 million convertible note offering.  Additionally, insider buying has surged, signaling strong corporate confidence. Key Corporate & Platform UpdatesGLP-1 Expansion: The telehealth platform expanded its weight-loss footprint internationally by launching generic semaglutide in Canada. Financial Moves: Prices for an upsized $350 million convertible senior notes offering were finalized to fuel international growth and accelerate AI-driven p

$香港交易所(00388)$  

$2倍做多MSFT ETF-Direxion(MSFU)$ 

$GME 20260702 27.0 CALL$  Sold another covered call after the previous one expired last friday. Continue to collect premiums as the stock figure itself out. 

$CVS VERTICAL 260618 CALL 96.0/CALL 95.0$  Started a position on CVS again as the chart still display bearishness, with no signs of bullish reversal of yet. 

$Intel(INTC)$  

$MU 20260605 675.0 CALL$ sad

$Broadcom(AVGO)$  Thank you for the ride again. 

$Hewlett Packard Enterprise(HPE)$  

$2倍做多TSLA ETF-Direxion(TSLL)$  

$NVIDIA(NVDA)$  

$Credo Technology Group Holding Ltd(CRDO)$ 

$Direxion Daily MU Bull 2X Shares(MUU)$  

$Zeta Global Holdings Corp.(ZETA)$ yes finally 😍

$iShares U.S. Aerospace & Defense ETF(ITA)$ 

$Invesco NASDAQ 100 ETF(QQQM)$ 

$NOK 20280121 20.0 CALL$ 

$NVDA 20260601 225.0 CALL$ thank you 

$CoreWeave, Inc.(CRWV)$ [财迷]